The report highlighted how the early use of lockdowns and other restrictions helped prevent widespread infection however the government was not well prepared.

Shares in VistaGen Therapeutics have plummeted after the company reported that its lead pherine nasal spray candidate failed the first of two phase 3 trials in social anxiety disorder (SAD ...